Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT05891483 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: SHR-1905 Injection
DRUG: SHR-1905 Placebo Injection

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd